Molecular mechanisms of regulation of neuronal muscarinic receptor sensitivity
- PMID: 2077364
- DOI: 10.3109/09687689009026820
Molecular mechanisms of regulation of neuronal muscarinic receptor sensitivity
Abstract
Like other neurotransmitter receptors, muscarinic acetylcholine receptors are subject to regulation by the state of receptor activation. Prolonged increases in the concentration of muscarinic agonists result in a decrease in receptor density and loss of receptor sensitivity, both in vivo and in vitro. On the other hand, when the receptor is deprived of acetylcholine for a long duration in vivo, the receptor becomes more sensitive in responding to muscarinic agonists. However, it has been more difficult to demonstrate increases in receptor concentration that accompany this supersensitive state. The purpose of this review is to provide current information related to the characteristics of muscarinic receptor regulation and the molecular mechanisms underlying this phenomenon, regarding both the density of receptors and their transduction mechanisms. Furthermore, possible feedback regulatory roles of different second messenger signals are discussed. Particular emphasis is dedicated to molecular mechanisms of regulation of neuronal muscarinic receptors.
Similar articles
-
Acute desensitization of phospholipase C-coupled muscarinic M3 receptors but not gonadotropin-releasing hormone receptors co-expressed in alphaT3-1 cells: implications for mechanisms of rapid desensitization.Biochem J. 1998 Jul 15;333 ( Pt 2)(Pt 2):301-8. doi: 10.1042/bj3330301. Biochem J. 1998. PMID: 9657969 Free PMC article.
-
Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain.J Pharmacol Exp Ther. 1984 Jan;228(1):209-14. J Pharmacol Exp Ther. 1984. PMID: 6141277
-
Agonist-induced down-regulation and antagonist-induced up-regulation of m2- and m3-muscarinic acetylcholine receptor mRNA and protein in cultured cerebellar granule cells.Mol Pharmacol. 1993 Nov;44(5):940-9. Mol Pharmacol. 1993. PMID: 8246917
-
On the site of interaction of some muscarinic agonists and competitive antagonists.Farmaco. 1989 Oct;44(10):897-909. Farmaco. 1989. PMID: 2695098 Review.
-
Muscarinic cholinergic agonists: pharmacological and clinical perspectives.Prog Brain Res. 1986;70:485-98. doi: 10.1016/s0079-6123(08)64324-1. Prog Brain Res. 1986. PMID: 3554361 Review. No abstract available.
Cited by
-
Pharmacological evaluation of the long-term effects of xanomeline on the M(1) muscarinic acetylcholine receptor.PLoS One. 2010 Dec 23;5(12):e15722. doi: 10.1371/journal.pone.0015722. PLoS One. 2010. PMID: 21203415 Free PMC article.
-
Immediate and delayed consequences of xanomeline wash-resistant binding at the M3 muscarinic receptor.Neurochem Res. 2009 Jun;34(6):1138-49. doi: 10.1007/s11064-008-9886-3. Epub 2008 Dec 12. Neurochem Res. 2009. PMID: 19082883 Free PMC article.
-
Long-term carbachol treatment-induced down-regulation of muscarinic M2-receptors but not m2 receptor mRNA in a human lung cell line.Br J Pharmacol. 1995 Oct;116(3):2027-32. doi: 10.1111/j.1476-5381.1995.tb16407.x. Br J Pharmacol. 1995. PMID: 8640341 Free PMC article.
-
Mechanisms of M3 muscarinic receptor regulation by wash-resistant xanomeline binding.Pharmacology. 2009;83(5):301-17. doi: 10.1159/000214843. Epub 2009 Apr 28. Pharmacology. 2009. PMID: 19401618 Free PMC article.